Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 2.6/5
Laurus Labs (LAURUS IN)
Watchlist
Contact IR
59
Analysis
Health Care
•
India
Laurus Labs Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) in India and internationally. It offers APIs for anti-retroviral and hepatitis C; and APIs in oncology and other therapeutic areas. .
more
Watchlist
Contact IR
Filings
Presentations
Events
Earnings/Op Data
New
Refresh
Exchange Announcement •
17 Jul 2024 13:28
Laurus Labs Ltd - 540222 - Update On Our Disclosure Dated April 25, 2024 Regarding The Appointment Of Directors.
Attachment
Exchange Announcement •
15 Jul 2024 10:16
Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachment
Exchange Announcement •
11 Jul 2024 18:03
Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Attachment
Exchange Announcement •
11 Jul 2024 16:11
Laurus Labs Ltd - 540222 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attachment
Exchange Announcement •
29 Jun 2024 11:06
Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of SEBI LODR
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x